Viruses (Apr 2022)

Molecular Characterization and Identification of Potential Inhibitors for ‘E’ Protein of Dengue Virus

  • Rishi Gowtham Racherla,
  • Sudheer Kumar Katari,
  • Alladi Mohan,
  • Umamaheswari Amineni,
  • Manohar Badur,
  • Abhijit Chaudhury,
  • Mudhigeti Nagaraja,
  • Sireesha Kodavala,
  • Meenakshi Kante,
  • Usha Kalawat

DOI
https://doi.org/10.3390/v14050940
Journal volume & issue
Vol. 14, no. 5
p. 940

Abstract

Read online

Dengue is an arthropod-borne acute febrile illness caused by Dengue Virus (DENV), a member of Flaviviridae. Severity of the infection ranges from mild self-limiting illness to severe life-threatening hemorrhagic fever (DHF) and dengue shock syndrome (DSS). To date, there is no specific antiviral therapy established to treat the infection. The current study reports the epidemiology of DENV infections and potential inhibitors of DENV ‘E’ protein. Among the various serotypes, DENV-2 serotype was observed more frequently, followed by DENV-4, DENV-1, and DENV-3. New variants of existing genotypes were observed in DENV-1, 2, and 4 serotypes. Predominantly, the severe form of dengue was attributable to DENV-2 infections, and the incidence was more common in males and pediatric populations. Both the incidence and the disease severity were more common among the residents of non-urban environments. Due to the predominantly self-limiting nature of primary dengue infection and folk medicine practices of non-urban populations, we observed a greater number of secondary dengue cases than primary dengue cases. Hemorrhagic manifestations were more in secondary dengue in particularly in the pediatric group. Through different computational methods, ligands RGBLD1, RGBLD2, RGBLD3, and RGBLD4 are proposed as potential inhibitors in silico against DENV-1, -2, -3, and -4 serotypes.

Keywords